Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Humira
Humira
AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle
Fierce Pharma
Sun, 02/9/20 - 04:19 pm
AbbVie
Humira
generics
patents
AbbVie's plan to replace Humira is ahead of schedule
BioPharma Dive
Fri, 02/7/20 - 11:48 pm
AbbVie
Humira
Skyrizi
immunology
Should AbbVie break up Allergan? If it wants to make up for Humira, then yes, analyst says
Fierce Pharma
Tue, 01/7/20 - 10:49 pm
AbbVie
Allergan
M&A
Humira
Botox
Roche's Ocrevus, GSK's Dovato ads top November TV spending charts—behind Humira, of course
Fierce Pharma
Thu, 12/19/19 - 11:06 pm
drug ads
television ads
Roche
Ocrevus
GSK
Dovato
AbbVie
Humira
UCB posts more supportive data from Humira rival bimekizumab
Pharmaforum
Fri, 12/6/19 - 09:31 pm
UCB Pharma
bimekizumab
AbbVie
Humira
psoriasis
biosimilars
FDA approves latest Humira near-copy, as dozens of biosimilars head for market
Pharmaforum
Mon, 11/18/19 - 10:11 am
FDA
Pfizer
biosimilars
Humira
AbbVie
Abrilada
Eli Lilly's Taltz extends its head-to-head Humira beat with 52-week psoriatic arthritis data
Fierce Pharma
Tue, 11/12/19 - 09:51 am
Eli Lilly
Taltz
psoriatic arthritis
AbbVie
Humira
3 Most Important Takeaways From AbbVie's Q3 Results
Motley Fool
Sun, 11/3/19 - 11:23 pm
AbbVie
earnings
Humira
Imbruvica
Novartis’ Cosentyx Narrowly Misses Beating Out AbbVie’s Humira in Arthritis Trial
BioSpace
Fri, 11/1/19 - 11:50 am
Novartis
Cosentyx
AbbVie
Humira
clinical trial
psoriatic arthritis
AbbVie, Gilead and Allergan 3-peat with September's top pharma TV spending
Fierce Pharma
Tue, 10/15/19 - 11:58 am
DTC ads
television ads
AbbVie
Humira
Gilead Sciences
Truvada
Allergan
Botox
Humira, Rituxan top list of U.S. drugs with biggest price increases -report
Yahoo/Reuters
Tue, 10/8/19 - 09:23 am
ICER
drug pricing
AbbVie
Humira
Roche
Rituxan
Merck, BMS, AbbVie blockbusters will rule pharma sales in 2025: report
Fierce Pharma
Fri, 10/4/19 - 12:44 pm
Merck
Keytruda
Bristol-Myers Squibb
Pfizer
Eliquis
AbbVie
Humira
AbbVie's Latest FDA Approval Is Its Most Important Immunology Win Since Humira
Motley Fool
Tue, 08/20/19 - 10:39 am
AbbVie
Rinvoq
Humira
immunology
These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024
Yahoo/Motley Fool
Sun, 08/4/19 - 01:02 pm
Merck
Keytruda
AbbVie
Humira
Pfizer
Bristol-Myers Squibb
Eliquis
JNJ
Imbruvica
5 Things You Need to Know From AbbVie's Q2 Earnings Results
Motley Fool
Sat, 07/27/19 - 02:03 pm
AbbVie
Humira
Venclexta
Imbruvica
hepatitis C
earnings
AbbVie's psoriasis launch Skyrizi hitting stride ahead of FDA's decision on upadacitinib
Fierce Pharma
Fri, 07/26/19 - 12:07 pm
AbbVie
Humira
biosimilars
Europe
psoriasis
rheumatoid arthritis
Skyrizi
FDA-approved Humira copycat from Merck, Samsung Bioepis will wait 4 years to launch
Endpoints
Wed, 07/24/19 - 10:07 am
Merck
Samsung Bioepis
FDA
Humira
AbbVie
drug launches
biosimilars
Merck's biosimilar to AbbVie's Humira wins FDA approval
Reuters
Tue, 07/23/19 - 07:35 pm
Merck
Hadlima
biosimilars
FDA
AbbVie
Humira
Pfizer's Xeljanz drops off top June TV spenders list—and Gilead's Biktarvy fills the void
Fierce Pharma
Thu, 07/11/19 - 09:45 am
AbbVie
Humira
Gilead Sciences
Biktarvy
Truvada
Pfizer
Xeljanz
television ads
DTC ads
Why AbbVie's Stock Sank in the First Half of 2019
Motley Fool
Fri, 07/5/19 - 01:51 pm
AbbVie
Humira
biosimilars
M&A
Allergan
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »